MITRA DELSHAD: Open Payments
NPI 1659735637 · CHICO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,167 in 98 payments from 22 companies in 2025. Trend: 2023 $2,716 · 2024 $2,793 · 2025 $2,167
Food & beverage: $2,167
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $382 |
| Axsome Therapeutics, Inc. | 6 | $309 |
| Daiichi Sankyo Inc. | 13 | $247 |
| Novo Nordisk Inc | 8 | $236 |
| Vanda Pharmaceuticals Inc. | 11 | $183 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $163 |
| AstraZeneca Pharmaceuticals LP | 2 | $136 |
| Abbott Laboratories | 1 | $94 |
| Exact Sciences Corporation | 5 | $78 |
| Dexcom, Inc. | 2 | $47 |
Products named: QULIPTA, Auvelity, INJECTAFER, FANAPT, Kerendia, Ozempic, BREZTRI, JOT DX.
Industry payments across CA — which companies pay providers there.
